Brief: RenovoRx Strengthens IP Portfolio With Eighth U.S. Patent
05/01/2023 14:27
Jan 5 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX STRENGTHENS INTELLECTUAL PROPERTY (IP) PORTFOLIO
WITH
EIGHTH US PATENT
* RENOVORX INC - PATENT BROADLY COVERS METHODS FOR TREATING
BILE
DUCT CANCER
Source text for Eikon: ID:nBw5V7dt5a
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies